Both in Surgical Instruments
Orchestra BioMed Holdings vs Carlsmed
Over the past year OBIO returned +58.3% and CARL returned +17.8%; their daily moves had a correlation of 0.18.
OBIO +58.3% CARL +17.8%Growth of $1, one year, split-adjusted
| Metric | OBIO | CARL |
|---|---|---|
| Price | $6.00 | $15.46 |
| Market cap | $360.6M | $422.0M |
| Today | +3.81% | +0.23% |
| 1 month | −1.3% | +9.7% |
| 6 months | +57.9% | +75.0% |
| Year to date | +44.6% | +25.1% |
| 1 year | +51.9% | +14.1% |
| Revenue growth (YoY) | −89.5% | — |
| Gross margin | 71.6% | 76.8% |
| Net margin | −27362.5% | −55.5% |
| P/E (TTM) | — | — |
| Price / sales | 11.3× | 6.7× |
| Net cash | $75.1M | $73.8M |
| Dividend yield | — | — |
| Volatility (60d) | 63.0% | 45.2% |
| Short % of float | 8.1% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).